<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[PSYCHEDSTUDIO - Medium]]></title>
        <description><![CDATA[Exploring psychedelics through social, economic, and political perspectives - Medium]]></description>
        <link>https://medium.com/psychedstudio?source=rss----64102bad6192---4</link>
        <image>
            <url>https://cdn-images-1.medium.com/proxy/1*TGH72Nnw24QL3iV9IOm4VA.png</url>
            <title>PSYCHEDSTUDIO - Medium</title>
            <link>https://medium.com/psychedstudio?source=rss----64102bad6192---4</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 08:41:17 GMT</lastBuildDate>
        <atom:link href="https://medium.com/feed/psychedstudio" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Psychedelic VC: Equitable Compensation in Inequitable Industries]]></title>
            <link>https://medium.com/psychedstudio/psychedelic-vc-equitable-compensation-in-inequitable-industries-f4e811f62850?source=rss----64102bad6192---4</link>
            <guid isPermaLink="false">https://medium.com/p/f4e811f62850</guid>
            <category><![CDATA[angel-investors]]></category>
            <category><![CDATA[psychedelics]]></category>
            <category><![CDATA[investing]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <dc:creator><![CDATA[Marik Hazan]]></dc:creator>
            <pubDate>Thu, 13 May 2021 02:35:58 GMT</pubDate>
            <atom:updated>2021-05-13T02:34:26.210Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*btDgKiu9ZSjc71oxhj-quQ.jpeg" /></figure><p>When a startup breaks up equity you see the first 80% split between the cofounders, 10% for early hires, and another 10% as an employee options pool. That’s the standard.</p><p>That means while a co-founder can see 20–30% of the equity, the acting CTO at an early stage organization might only see 1% depending on whether they’re part of the founding team or not.</p><p>I’ve seen countless friends take a “first-hire” job and be left with decimal-place equity while doing more of the work than either founder.</p><p>Sometimes you’ll stumble into co-founders who have an unequal equity split, one of them claiming that they brought in the initial capital, had the idea, or that they were the “first”. Experts like Michael Siebel, the current head of YCombinator suggest that equity is always split equally between founders. Less drama down the road.</p><p>In VC the same problem arises. General Partners typically take home all the <em>carry</em>, with many employees not taking even a bit of the cut. And for anyone who’s familiar with venture, you know that carry is where all of the real money is made.</p><p>For those who are newer to VC, there are two ways that the operators of a venture firm get paid: management fees and carry.</p><p>Especially for small funds, $25M for instance, the standard management fees of 2% per year are just too small ($500k) to support a whole team, operations, audits, marketing, press, fund administration, etc. Salaries are low, ours are $30k for the first fund, and make living on a VC salary impossible until the firm gets up to funds that are larger than $50M. Perhaps $30k is enough for living expenses in a small city, but most VC’s need to have their members located in or near big cities to have access to the biggest investors and the best deals. $30k in New York or SF won’t get you far, especially if you’re a younger investor paying off student loans or a new parent trying to support your family.</p><p>But “Carry” is where things get interesting. Let’s say you make a 2.5x return which is inline with top-quartile funds. That means you’ll make just shy of around $40M in returns over the initial $25M that has been invested. Carry is split 80–20 between investors and the firm, so 20% of 40M becomes $8M, your split of the winnings. There are details that I’m purposely excluding here which make this number smaller, but even if we assume the firms carry at the end of the day amounts to $5M, that’s still $1M in the bank accounts of each team member in a 5 person team.</p><p>This doesn’t happen over 1 year, but over 10, though even when it’s prorated over that time period there is still a $100k increase per year in salary for those involved.</p><p>Unfortunately, the split of carry happens in a much less egalitarian way. Typically GPs will take the majority of those winnings, 80%, and leave the rest for venture partners, principles, and other key contributors to the organization.</p><p>We decided to make two significant changes.</p><p>Firstly, we decided to <em>vest</em> our carry, something we haven’t seen done by other firms we’ve been in conversation with. If a key individual leaves we will be able to bring in someone else and still compensate them fairly and competitively. Secondly, we split our equity via a salary based model. Basically we looked at carry as an extension of salary instead of a bonus won whenever a company would exit.</p><p>This allowed us to create a much more even split for our firm that made the prorated wages of each member of our team equal, livable, de-risked, and fair.</p><p>We were met with critiques from investors who commented that “socialist compensation structures” don’t work to incentivize employees.</p><p>We had internal discussions about who holds the liability within the fund and how should that be compensated relative to everything else?</p><p>Some of our team had more experience, more connections, more access to capital, but at the end of the day we are all still learning and equally as dedicated to seeing our work flourish.</p><p>And what we found in the research was that we needed an alternative compensation structure to what was out there. Compensation is much less about absolute pay and much more about relative pay. And when you have contributors who helped build a firm over years of time, then the most important rule is that<em> no one feels that they were disrespected</em>.</p><p>The priority in building early stage projects of any sort is creating a foundation of trust. That is difficult to do when people tier themselves financially from the outset.</p><p>As we continue to work with dozens of startups in the psychedelics ecosystem we will continue to push the limits on egalitarian compensation structures that keep everyone well fed while making sure that everyone feels equally appreciated for their contributions.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f4e811f62850" width="1" height="1" alt=""><hr><p><a href="https://medium.com/psychedstudio/psychedelic-vc-equitable-compensation-in-inequitable-industries-f4e811f62850">Psychedelic VC: Equitable Compensation in Inequitable Industries</a> was originally published in <a href="https://medium.com/psychedstudio">PSYCHEDSTUDIO</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[100 Most Influential People in Psychedelics]]></title>
            <link>https://medium.com/psychedstudio/100-most-influential-people-in-psychedelics-6fa429968b10?source=rss----64102bad6192---4</link>
            <guid isPermaLink="false">https://medium.com/p/6fa429968b10</guid>
            <category><![CDATA[therapy]]></category>
            <category><![CDATA[investment]]></category>
            <category><![CDATA[psychology]]></category>
            <category><![CDATA[psychedelics]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <dc:creator><![CDATA[Marik Hazan]]></dc:creator>
            <pubDate>Tue, 04 May 2021 16:50:02 GMT</pubDate>
            <atom:updated>2021-05-14T02:08:48.729Z</atom:updated>
            <content:encoded><![CDATA[<p><em>How do we define influence in the psychedelics ecosystem?</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*pujGlDrhkrPZmeMVBWnmyQ.png" /></figure><p>Authored by: Maya Albert, Lilia Karimi, Tammy Sanders, Marik Hazan</p><p>Our team woke up on May 1st to see a list published by <em>Psychedelic Invest</em> of the<a href="https://psychedelicinvest.com/most-influential-people-psychedelics-2021/"> 100 most influential people in psychedelics</a>.</p><p>I was grateful to have my own work acknowledged (I was #96), but before even opening the article, our team was concerned by the fact that there were some serious names and faces missing. While all of the people in the cover art may have had significant influence on the development of psychedelics, there have also been hundreds of individuals who don’t fit the “majority” demographic who have had even more impact on the development of this ecosystem than many of the individuals mentioned.</p><p><em>Soon after the article was published the image was taken down and </em><a href="https://psychedelicinvest.com/creating-a-sustainable-psychedelics-ecosystem/"><em>this statement</em></a><em> was published by Psychedelic Invest.</em></p><p><strong>Our work revolves around depolarizing this space.</strong> There were many people who were upset by the article and <em>we hear you</em>. To the folks at <a href="https://psychedelicinvest.com/">Psychedelic Invest</a>, we don’t want to vilify your work. We want to be of service.</p><p>How can <a href="https://www.energia.co/">our organization</a> be helpful to your own in drawing attention to the important work that is being done by BIPOC and female leaders all across the ecosystem?</p><p>We’re by no means perfect, but we want you to know that we’re available to you in the future. These lists hold weight and the more siloed off we are from one another, the poorer the results from all our efforts. Feel free to reach out to us and if you’d like our help or perspective we’d be happy to direct you toward people who know much more than ourselves about who has been most influential in the global rollout, accessibility, influence, and progress of psychedelic medicines and compounds.</p><h3>Intention</h3><p>Firstly, this is V1 of our own attempt at crafting such a list. We will continue iterating and want to hear from you. Who else deserves to be recognized below? Message us at team@psyched.studio.</p><p>The intention of our list was not to create one that featured every person Psychedelic Invest’s list didn’t include. It also isn’t intended to solely highlight activists, healers, or underrepresented groups. Instead, we wanted to create a list in the same vein as Psychedelic Invest created, but with what we believe is a more holistic understanding of how this ecosystem operates and runs.</p><p>The way we define influence is: <strong>Executing on actions today that already are or will influence the way millions of people interact with, understand, and adopt psychedelics into their own lives.</strong></p><p>Is our list still White male-dominant? Yes. But we want that to serve as a reminder of how much work there is still to be done in providing greater access, more platforms, and more resources to BIPOC and female leaders whose work is noteworthy and already impacting millions of people.</p><h3>Conditions</h3><ol><li>All of the people on this list are currently living and actively contributing to the psychedelics space. Contributors to the psychedelics ecosystem would number in the thousands if we didn’t have this boundary setting. María Sabina, Kilindi Iyi, Terence McKenna, and hundreds of others would have made it impossible to choose. Perhaps we’ll write a follow up post focused on all those who came before us.</li><li>The individuals we list are those who have translated the power of psychedelics into a language and framework that is more easily comprehensible to global, multicultural, and cosmopolitan society.</li><li>The individuals listed here have not necessarily been “positive” for the future of psychedelics, but they have indeed been influential in its unfolding on a global scale. We do not support or condone the approach of any individual on this list simply by naming them here. Instead, we chose individuals solely in accordance with their influence (in the way that we’ve defined it).</li></ol><h3>Methodology</h3><p>The way in which this list was compiled was through informally surveying the ecosystem for individuals that community members believe have been most influential in the continued development of the space. There are definitely people that we have missed out on and so we encourage you to submit the names of individuals who you think should be featured here as well: team@psyched.studio.</p><p>Lastly, <strong>our list is alphabetized</strong> instead of numerical. We felt it was unfair to tier considering how different each individual’s influence is and wanted to prioritize collaboration instead of competition. Also, in specific instances, we included teams instead of a sole influencer.</p><p>Short List Here, Detailed Below</p><ol><li>Amanda Feilding</li><li>Ancestors project — Charlotte James, Undrea Wright</li><li>Anne Philippi</li><li>ATAI — Christian Angermayer, Florian Brand, Lars Christian Wilde</li><li>Ben De Loenen</li><li>Ben Sessa</li><li>Bia Labate</li><li>Robert (Bob) Jesse</li><li>Bruce Tobin</li><li>Dr. Carl Hart</li><li>Chi Psilocybin</li><li>Chris Dyer</li><li>Colin Pugh</li><li>Compass — Ekaterina Malievskaya, George Goldsmith</li><li>CoSM — Allison &amp; Alex Grey</li><li>Daiara Hori Figueroa Sampaio</li><li>Danny Motyka</li><li>Darren Springer</li><li>David Bronner</li><li>David Champion</li><li>David Nichols</li><li>David Nutt</li><li>Dawn D. Davis</li><li>Dennis McKenna</li><li>Deran Young</li><li>Dick Simon</li><li>DoubleBlind — Shelby Hartman, Madison Margolin</li><li>Duncan Trussel</li><li>Dylan Beynon</li><li>Fluence — Ingmar Gorman, Elizabeth Nielson</li><li>Francois Bourzat</li><li>Gabor Mate</li><li>Hamilton Morris</li><li>Intercollegiate Psychedelics Network (IPN) — Emily Cribas, Margaret Fleming, Rahul Sood, Victor Acero, Alex Zhao, Kenneth Shinozuka, Elin Ahlstrand</li><li>Ismail Ali</li><li>Jade Netanya</li><li>James Fadiman</li><li>Jamilah George</li><li>Janis Phelps</li><li>Jasmine Virdi</li><li>Jesse Gould</li><li>Joe Rogan</li><li>Journey Colab — Sutton King, Jennifer Pisansky</li><li>JR Rahn</li><li>Juliana Mulligan</li><li>Julie Holland</li><li>Kamya Buch</li><li>Kevin Matthews</li><li>Lucid News: Ken Jordan, Annie Oak</li><li>Kufikiri Imara</li><li>Kwasi Adusei</li><li>Lia Mix</li><li>Liana Gillooly</li><li>Lucia Huang</li><li>Luis Tamani</li><li>Lynn Marie Morski</li><li>Manuela Mahua</li><li>Mareesa Stertz</li><li>Matthew Johnson</li><li>Mendel Kaelan</li><li>Michael Pollan</li><li>Mike Margolies</li><li>Mike Tyson</li><li>Mohawk Greene</li><li>Molly Maloof</li><li>Dr. Monnica T. Williams</li><li>Natalie Ginsberg</li><li>North Star — Kat Conour, Dave McGaughey, Liana Gillooley, Shirelle Noble, Tim Chang</li><li>Oregon Initiative — Tom Eckert, Sheri Eckert (Posthumous), Sam Chapman</li><li>Paul Austin</li><li>Paul Stamets</li><li>Plant Medicine Law Group — Hadas Alterman, Adriana Kertzer, Serena Wu</li><li>Psychedelic Societies</li><li>Psychedelics Today — Joe Moore, Kyle Buller</li><li>Psymposia</li><li>Rachel Yehuda</li><li>Richard Skaife</li><li>Rick Doblin</li><li>Rick Strassman</li><li>Rob Laurie</li><li>Robin Carhart Harris</li><li>Roland Griffiths</li><li>Ronan Levy</li><li>Rosalind Watts</li><li>Saad Shah</li><li>Sandor Iron Rope</li><li>Sara Reed</li><li>Shlomi Raz</li><li>Simeon Schnapper</li><li>Sophia Rokhlin</li><li>Stanislav Grof</li><li>Tania De Jong</li><li>Tim Ferris</li><li>Todd Shapiro</li><li>USONA</li><li>Vine Ventures — Ryan Zurrer, Jesse Hudson</li><li>Yann Guignon</li><li>Yarelix Estrada</li><li>Zach Haigney</li><li>Zoe Helene</li></ol><h3>Posthumous Recognition:</h3><p>These are individuals who would have been on our list, but passed in 2020.</p><p><strong>Sheri Eckert<br>Kilindi Iyi<br>Jordi Riba</strong></p><p><em>Thank you for your work and your prophecies, for everything you did to move this movement forward and help our societies take further steps towards the liberation of the heart, mind, soul, and conscious.</em></p><p>If you didn’t see your name on here, don’t worry. We have a list of 100 Prominent Voices that we’ll be releasing in the coming weeks.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/512/1*Hg2b7afRb-T6QH4aSGqO_Q.jpeg" /></figure><h3>Amanda Feilding</h3><p>Amanda Feilding is Director of the Beckley Foundation, a UK-based think tank and UN-accredited NGO, which she founded in 1998. Its chief objectives are studying the mechanisms underlying altered states of consciousness and reforming global drug policy. She is dubbed the ‘hidden hand behind the renaissance of psychedelic science and drug policy reform.” Through the Scientific Programme, Amanda orchestrates collaborations with leading scientists worldwide, investigating cannabis, psilocybin, LSD, Ayahuasca, DMT and MDMA. Through the Policy Programme, Amanda advocates policy-making informed by scientific evidence. She has established a seminar series, Drugs &amp; Society: A Rational Perspective, producing over 40 books and policy reports. Amanda advises world leaders on policy reform– most recently the Jamaican government on forming their cannabis industry.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1020/1*s4Kdb9pvw2nUBwTJItaiVQ.jpeg" /></figure><h3>Ancestors Project</h3><h4>Charlotte James, Undrea Wright</h4><p>The Ancestor’s Project has pioneered the intersection of ancestral wisdom and modern journeying. Working mostly with Kambo and Rapeh, legal plant medicines used throughout the Amazon, Charlotte and Undrea (Dre), the two cofounders, have led the conversation around what it means to connect to ancestral knowledge in modern healing spaces. Ancestor’s project has also helped continue the diversification of the psychedelic ecosystem through their Mutual Ceremony Fund, allowing BIPOC individuals who may have previously not had access to Sacred Earth Medicine ceremonies to participate.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/350/1*C-K9k-aQbNCLGxdg5eOmtQ.jpeg" /></figure><h3>Anne Philippi</h3><p>Anne Philippi was a journalist for Conde Nast and Rolling Stone, lived in Los Angeles and is now based in Berlin. She writes for Frankfurter Allgemeine Zeitung, is a book author and now the founder/ CEO of The New Health Club, a lifestyle platform for the age of mental wellness and psychedelics, creating podcasts, newsletter and an upcoming show about modern healing stories.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MQV3HlpLkYpj1T6Qf2TPRg.jpeg" /></figure><h3>ATAI</h3><h4>Christian Angermayer, Florian Brand, Lars Christian Wilde</h4><p>As one of the most controversial companies in the psychedelics ecosystem, ATAI has led the psychedelic space through its acquisitions of drug development/pharmaceutical companies developing psychedelic compounds and moving these medicines through the FDA approval process.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*8o2A4DdMxXGS7wWV3xIUng.jpeg" /></figure><h3><strong>Ben De Loenen</strong></h3><p>Benjamin De Loenen, M.A., is dedicated to making Ayahuasca, Iboga and other traditional plant practices valued and integrated parts of society. In 2009, he founded the International Center for Ethnobotanical Education, Research &amp; Service (ICEERS), a charitable non-profit organization with United Nations consultative status, where he serves as Executive Director. Benjamin is the author of several publications and films, has presented at conferences around the world, and has participated in various leadership roles, including as a member of the Board of Directors of the Global Ibogaine Therapist Alliance (2012–2014).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/640/1*O40bU6-sTOQBCqZrGtZtOg.jpeg" /></figure><h3>Ben Sessa</h3><p>Ben Sessa is an English psychiatrist, researcher, and author. Dr. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/380/1*CtZZvkHrGP6PV_RRA4-n_A.jpeg" /></figure><h3>Bia Labate</h3><p>Bia Labate has a Ph.D. in Anthropology. Her main areas of interest are the study of psychoactive substances, drug policies, shamanism, ritual, and religion. Today, she is the Public Education and Culture Specialist at MAPS, and Adjunct Faculty at the East West Psychology Program at the California Institute of Integral Studies (CIIS). She is also the founder of the Interdisciplinary Group for Psychoactive Studies (NEIP) in Brazil and Chacruna, a platform devoted to public education and cultural understanding about psychedelic plant medicines. She is an author, co-author, and co-editor of twenty-one books, two special-edition journals, and several peer-reviewed articles.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*-cNC4MU8glS31YheUGEjbw.jpeg" /></figure><h3>Robert (Bob) Jesse</h3><p>Robert Jesse was instrumental in forming the psilocybin research team at Johns Hopkins and has co-authored several of its papers, including “Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance” (2006). In 2017, Bob led the drafting of a public statement, now signed by numerous leaders in the field, raising Open Science as a psychedelic ideal. In 2005, he led the writing of an amicus brief for the U.S. Supreme Court in the União do Vegetal religious liberty case, decided 8–0 favoring the church. In 1995, he led the development of a Code of Ethics for Spiritual Guides (csp.org/code). Currently, he serves on the boards of Usona Institute and the George Sarlo Foundation. Earlier in life, Bob trained at Hopkins in electrical engineering and computer science, consulted for AT&amp;T Bell Labs, and worked at Oracle, lastly as a VP of business development.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/276/1*3bP3YyrbGGFPJ0CsA8Z7pQ.png" /></figure><h3>Bruce Tobin</h3><p>Dr. Bruce Tobin is a clinical psychologist and Founder and Chair of the nonprofit organization TheraPsil based in Victoria, British Columbia, a coalition of healthcare professionals, advocates and stakeholders dedicated to helping Canadians receive therapeutic access to psilocybin. He received his Doctorate in Philosophy of Psychology and specializes in treating individuals with anxiety, depression, and emotional trauma. He has also taught clinical skills as an Adjunct Professor at the University of Victoria for 25 years. In 2020, TheraPsil began a program to help patients apply for their own Section 56 exemptions.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*P83SPdQdCZyipErG5Jxo1w.jpeg" /></figure><h3>Carl Hart</h3><p>Dr. Carl Hart is a professor of neuroscience and psychology at Columbia University. Hart is known for his research in drug abuse and drug addiction. Dr. Hart has appeared on multiple podcasts, radio and television shows including Real Time with Bill Maher, The O’Reilly Factor, and the Joe Rogan Experience. He has also appeared in several documentary films including the award-winning “The House I Live In.”</p><p>Dr. Carl Hart’s controversial view on drugs such as Heroine have quickly brought him to the forefront of the conversation around psychoactive compounds. Concepts such as psychedelic exceptionalism have been pioneered by his work and research.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/230/1*LUmY-OzC9r7BmsYuTUiNiw.jpeg" /></figure><h3>Chi Psilocybin</h3><p>Chi Psilocybin is a psilocybin guide, advocate, and retreat facilitator. He is the co-founder of Truffles Therapy, a psilocybin retreat organization that has guided hundreds of people on their journeys. He also helped form the founders of Global Alliance of Psilocybin Practitioners, which provides community, training, and mentorship for guides and connects those seeking the medicine with those providing safe access. They advise individuals and companies involved in the emerging psychedelic industry.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/851/1*LdFTDJ6_RnxuTYqGvbgzhQ.jpeg" /></figure><h3>Chris Dyer</h3><p>Chris Dyer is a Peruvian artist, currently living in Canada, and traveling the world half of his time. He experiences different cultures and then re-expresses them into his own oneness visions. He serves as a Bridge builder between different art movements from skateboard graphics, visionary paintings, street art murals and more. He wants to break boxes and see everything as one optimistic reality. Though his subject matters are as varied as his styles, his art is just a reflection of his personal spiritual journey. With hundreds of thousands of Instagram followers, Dyer’s unique art style combines visionary art and street art, creating one of the most extremely unique genres of painted media. Prolific in conversations around Ayahuasca, meditation, and other psychedelic plant medicines, Dyer continues to lead the conversation around visionary art and its evolution.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*zda3ew8pi0jaerSXgM4WEA.jpeg" /></figure><h3>Colin Pugh</h3><p>Colin Pugh is the President of the Brooklyn Psychedelic Society, a community that supports individuals who are pursuing transformative psychedelic experiences. They are sponsored by MAPS, and have a mission to make psychedelic healing a publicly accessible good through community, education, democratic ownership, and advocacy. Colin’s visionary approach to the role that psychedelic societies should play within our ecosystem has led to the formation of a co-op that will provide PAT to those in need of healing. This is the first initiative of its kind and will set an example for psychedelic societies globally regarding what can be done at the intersection of community, healing, support and distributed financial ownership.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/820/1*Fjr30htTTSr3MFmkTKovNA.jpeg" /></figure><h3>COMPASS</h3><p>While COMPASS has undoubtedly been the most controversial company to enter the psychedelic ecosystem, their existence has helped spark many of the foundational conversations around psychedelics and capitalism, patents on therapeutic treatments, and the intersection of nonprofits and for profits in the space. They have left a long lasting imprint on how psychedelic business will evolve and will continue to be a reference for activists, policy makers, and entrepreneurs for decades to come.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/512/1*DY3x7zn8UV6-HH7mlr0xEQ.jpeg" /></figure><h3>CoSM</h3><p>The Chapel of Sacred Mirrors is a non-profit and interfaith church, formed in 1996 to create a permanent public exhibition of the Sacred Mirrors. Alex and Allison are American visual artists, authors, and teachers, known for creating spiritual and psychedelic paintings. They work in multiple forms including performance art, process art, installation art, sculpture, visionary art, and painting. Their art has influenced the lives of many by communicating an aspect of the psychedelics world that words cannot describe.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*Tx-Nu7mrs99DOrZ320Aa9w.jpeg" /></figure><h3>Daiara Hori Figueroa Sampaio</h3><p>Born in São Paulo, Daiara is an artist, activist, educator and communicator. She has her Masters in Human Rights from the University of Brasília, and is a researcher on the right of the memory and truth of indigenous peoples. She is also a coordinator of Radio Yandê, the first indigenous web-radio in Brazil. She studies the culture, history and traditional spirituality of its people next to its family.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*AR5Qb3EyY1qJUV90atku3g.jpeg" /></figure><h3>Danny Motyka</h3><p>Danny is the CEO of Psygen, a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications. He graduated from the University of Victoria with a degree in chemistry before becoming an early employee at Aurora Cannabis. His career with Aurora provided foundational experience in enterprise management, good manufacturing practices, and the Controlled Drugs and Substances Act.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/350/1*bDBr30uI4afEfFzgePGb5w.jpeg" /></figure><h3>Darren Springer</h3><p>Darren Springer is a mycologist and psychedelic researcher based in the UK. He is a member of the London Psychedelic Society and the Breaking Convention committee. Darren is a knowledgeable and dynamic speaker who is passionate about sharing his research and findings on ancient African plant medicines, the history, mythology and various applications. He is regular presenter at the Detroit Psychedelic Conference, Ozora, Noisily Festival, and numerous psychedelic gatherings around the world sharing his extensive research on psychedelics and how they can help support humanity in the here and now. His business efforts, community activism, online presence through his YouTube channel have all brought him into the hearts and minds of those seeking to understand psychedelics from dozens of perspectives provided by his guests and followers.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*tlVE46VnDFIAP_xXCnH83A.jpeg" /></figure><h3>David Bronner</h3><p>David Bronner is an American corporate executive and activist. As the top executive at Dr. Bronner’s Magic Soaps, he has become known for his activism around a range of issues, especially fair trade, sustainable agriculture, animal rights, and drug policy reform. In addition to significant funding initiatives, David also sits on the board of MAPS.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*8pH-Drvt8uHaUuMz-MzXXA.jpeg" /></figure><h3>David Champion</h3><p>David is the CEO of Maya, a psychedelic therapy intelligence platform designed to bring greater trust, transparency, and measurement to the participant journey. The platform is geared to become the world’s largest database of psychedelic health outcomes, fueling insights to help psychedelic healthcare scale safely. David also directs Unlimited Sciences, a psychedelic research nonprofit combining academia with data science to understand underground psychedelic practices and surface best practices to inform further research. In 2019, he served as a campaign-lead in the Denver Psilocybin Initiative, helping Denver become the first US city to reform psilocybin policy. Prior, David was Co-founder &amp; CPO at Baker Technologies, which he exited after achieving a valuation of $250MM.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*HdGxve6mpv4gZfNvMDkPdQ.jpeg" /></figure><h3>David Nichols</h3><p>David Earl Nichols is an American pharmacologist and medicinal chemist. David is the founding president of the Heffter Research Institute, has published hundreds of research papers, and is considered to be one of the world’s top experts on psychedelics.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/458/1*zyp38hPg-t9iiCyF9KnLVw.jpeg" /></figure><h3>David Nutt</h3><p>David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/502/1*qegOeWm4RI86MzB__vSStA.jpeg" /></figure><h3>Dawn D. Davis</h3><p>Dawn D. Davis, M.A., is a tribal person belonging to the membership of the Shoshone-Bannock Tribes of Fort Hall, Idaho. She holds a master’s degree from the University of Arizona where she completed her research on potential sustainability practices of peyote within its native range. She continues to discuss endangerment levels of peyote and preservation efforts among peyotists. Dawn is currently a Ph.D. student in the Water Resources Program at the University of Idaho with an emphasis in Law, Management, and Policy. Current research includes sustainability of ethno-significant plants, particularly medicinal plants and first foods, in addition to small-scale food and energy security. Previous research has led her to review Tribal policy through active participation by Tribal members in natural resource management from an Indigenous and community perspective. Dawn is a current National Science Foundation fellow under the Integrated Graduate Education and Traineeship (IGERT) program. In addition, she is a scholar of the Indigenous Program for STEM (ISTEM) research, including collaborative research funding from the Pacific Northwest Alliance. ­Dawn is married to Dr. Cleve Davis, is a mother, and a micro-farmer.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/762/1*jrXgMQDDJUdtc4Mk4-arzw.jpeg" /></figure><h3>Dennis McKenna</h3><p>Dennis McKenna is an American ethnopharmacologist, research pharmacognosist, lecturer and author. He has appeared on numerous media outlets, conducted a variety of research projects, and sits on the board of the Heffter Research Institute. He founded the McKenna Academy of Natural Philosophy in 2018, which the explores modern and traditional practices, ideas and technologies that foster the understanding of nature, consciousness, the cosmos and their interweavings with humanity.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/603/1*y74W1vziXtiaoA4ttUXlhA.jpeg" /></figure><h3>Deran Young</h3><p>Deran Young is the founder of Black Therapists Rock (BTR) which offers mentorship, knowledge sharing, and unity among professionals, and is now over 28k people strong. Deran has brought psychedelic education into the BTR community, an initiative that is becoming the largest global shift in who administers psychedelic healing with tens of thousands of diverse practitioners now exploring PAT as a result of her work.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*yjV6ih052I9p35tOEsKwPA.jpeg" /></figure><h3>Dick Simon</h3><p>Dick Simon is an entrepreneur, social enterprise philanthropist and catalyst for change. He co-founded the Peace Action Network (PAN) of YPO, a network of over 29,000 international CEOs. PAN addresses conflict resolution on local and global levels. He launched the kNOw THEM Initiative to raise awareness about the most dangerous four-letter word in the English language, THEM. Currently, he is involved with organizations pursuing FDA and European Medical Association clinical trials for mental health (PTSD, depression) treatments using psychedelic medicines. He is working to shift public perspective and reduce stigmatization related to the use of these medicines and is also working with researchers studying psychedelic treatments for a wide range of indications as well as their possible use in conflict resolution.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/1*MLmf9D4xV33KGgbwc7jcvQ.jpeg" /></figure><h3>DoubleBlind</h3><p>DoubleBlind is a biannual print magazine and media company covering timely, untold stories about the expansion of psychedelics around the globe. Madison is the Co-Founder, Managing Editor, covering psychedelics, cannabis, drug policy, and spirituality. She has traveled extensively, exploring the role of plant medicine in religion, mental health, and conflict resolution. She got her start in journalism with a column on cannabis at the Village Voice, after having lived in south Tel Aviv working with Eritrean refugees.Shelby is the co-founder and editor-in-chief of DoubleBlind. Her work has appeared in VICE, Quartz, the Huffington Post, and Rolling Stone, among others.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*D3Z7AbB2blD9ABvzIrzKew.jpeg" /></figure><h3>Duncan Trussel</h3><p>Duncan Trussell is an American actor, voice actor and stand-up comic, known for his podcast The Duncan Trussell Family Hour and as the co-creator of the Netflix series The Midnight Gospel. Duncan’s content has a wide reach and often discusses psychedelics, and their place in therapies and as medicine.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*mibIzHtHTwIkn8OdVj2TMA.jpeg" /></figure><h3>Dylan Beynon</h3><p>Dylan is the founder and CEO of Mindbloom, a platform that helps licensed psychiatric clinicians achieve better outcomes for their patients with lower costs, greater convenience, and an artfully crafted experience. Dylan grew up with serious mental illness in his family, and he lost his mom to it as a teenager. In 2009, his journey of healing and growth led to psychedelic medicine, and ketamine therapy, and it’s still changing his life.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/252/1*NfuCNOyQBSZxcBURKWXGgQ.jpeg" /></figure><h3>Fluence</h3><h4>Elizabeth Nielson, Ingmar Gorman</h4><p>Founded by Elizabeth Nielson and Ingmar Gorman, Fluence offers a series of continuing education programs in psychedelic integration and psychedelic-assisted therapy. Their programs are interactive, engaging in discussion, demonstration, self-reflection exercises, and role plays. The therapeutic training program at Fluence has grown to become the gold standard in therapist training across the psychedelic world and many programs that are now under development have looked to Fluence to craft their own programs for PAT training and accreditation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*F8XNwBx6GxuUGyOAR-etDQ.jpeg" /></figure><h3>Francois Bourzat</h3><p>Françoise Bourzat has been bridging the divide between western psychology and indigenous wisdom in collaboration with healers in Huaulta de Jiminez, Mexico for the past 30 years. She is a co-founder of the Center for Consciousness Medicine, which trains people to become guides in a holistic method of psychedelic assisted therapy. She is also the co-author of Consciousness Medicine, published by North Atlantic Books. Françoise served on the advisory board for the Oregon Prop 109 initiative and is currently collaborating with the Pacific Neuroscience Institute in an FDA-approved research study on psilocybin-assisted therapy for Covid-related grief. She has a Master of Arts in Somatic Psychology and is trained in the Hakomi Method. Françoise has taught at CIIS in San Francisco, is a counselor, and runs online courses and lectures in various institutions.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*mfVC8x-0DWX89Vkf7UMd6Q.jpeg" /></figure><h3>Gabor Mate</h3><p>Gabor Maté CM is a Hungarian-Canadian physician. He has a background in family practice and a special interest in childhood development and trauma, and in their potential lifelong impacts on physical and mental health, including on autoimmune disease, cancer, ADHD, addictions, and a wide range of other conditions. A renowned speaker, and bestselling author, Dr. Gabor Maté is highly sought after for his expertise on a range of topics including addiction, stress and childhood development. While some of his therapeutic approaches and beliefs around mental illness have been the subject of controversy, he has undoubtedly influenced many practitioners looking for a more accessible way of understanding how trauma arises and exists within the human mind and body.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*XKdanLWUaK5HEqtASz_44w.jpeg" /></figure><h3>Hamilton Morris</h3><p>Hamilton Morris is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series Hamilton’s Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/757/1*JFdsXDEVpKojVca-G_cpXQ.png" /></figure><h3>IPN</h3><h4>Emily Cribas, Margaret Fleming, Rahul Sood, Victor Acero, Alex Zhao, Kenneth Shinozuka, Elin Ahlstrand</h4><p>The Intercollegiate Psychedelics Network (IPN) is a youth-led umbrella organization dedicated to the development of students into the next generation of diverse and interdisciplinary leaders in the field of psychedelics. Co-created by 7 friends from Harvard, Penn, and Princeton, IPN has grown to a team of 33 volunteers all around the world, from the US to Canada to London to New Zealand. All of the founders started the respective psychedelics clubs at their schools, the Intercollegiate Psychedelics Summit (IPS), and this network. They share a vision of a future where safe, legal, and equitable access to psychedelic healing creates a more just, peaceful and connected world.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/550/1*Or0bFNANs7i4hKPwg09ROg.jpeg" /></figure><h3>Ismail Ali</h3><p>Ismail Ali is the Policy and Advocay Councel at MAPS. He helps develop sensible drug policy that will create alternatives to the failed war on drugs. He also serves on the board for Sage Institute and is a founding board member and current co-chair for the recently launched Psychedelic Bar Association.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/512/1*RNIh4p5IaVxWzICQcEJ-0Q.jpeg" /></figure><h3>Jade Netanya</h3><p>Jade Netanya Ullmann has been the Major Gifts Maven, Officer and Connector at MAPS for several years. She is a member of the Threshold Foundation’s Psychedelic Research Education &amp; Policy funders circle. She has been Pipeline Fellow angel investor that has supported female entrepreneurs who are running social ventures. Jade is a member of the Ullmann Family Foundation, Jewish Funders Network and serves on the board of Jewish Renewal Organisations Romemu and ALEPH.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*mK1ap-Ai23O9esWM7IDwPw.jpeg" /></figure><h3>James Fadiman</h3><p>James Fadiman is an American psychologist and writer, and very well know for his microdosing protocal. He is acknowledged for his extensive work in the field of psychedelic research. He co-founded along with Robert Frager the Institute of Transpersonal Psychology, which later became Sofia University, where he was a lecturer in psychedelic studies.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/280/1*cH-3pdbYroiu2VD1oGP0Fg.jpeg" /></figure><h3>Jamilah George</h3><p>Jamilah George is a a psychedelic-assisted therpaist specializing in Post Traumatic Stress Disorder, Discrimination and Ethnic Identity, and MDMA-assisted Therapy. She obtained her Masters of Divinity degree from Yale University and the Yale Institute of Sacred Music. She received intensive training in the Yale OCD Research Clinic on the Clinical Neuroscience Research Unit in the Yale Department of Psychiatry.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/363/1*Wj8pInyo3PxkJAB3zsYXtw.jpeg" /></figure><h3>Janis Phelps</h3><p>Janis Phelps, PhD leads The Center for Psychedelic Therapy &amp; Research at the California Institute for Integral Studies. She developed the first academically accredited, professional certificate training program for legal psychedelic-assisted therapy and research. The Center also provides harm reduction workshops, webinars on psychedelic research and public educational programs. A licensed clinical psychologist and LMFT, she has held faculty positions in the East-West Psychology and Clinical Psychology doctoral programs. Her theoretical orientations include transpersonal and wellness therapy models; Buddhism and Eastern disciplines; and phenomenology/existential philosophies. Her research and scholarly writing has focused on psychedelic therapy, entheogens, and mind-body wellness. Dr. Phelps teaches graduate courses in quantitative and qualitative research methods, mindfulness, Buddhism and psychotherapy, spiritual counseling, and principles of healing. Janis serves on the board of the Holos Institute and maintains a private practice.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/624/1*QM8qIaP9Sf9EVs20pXuAOw.png" /></figure><h3>Jasmine Virdi</h3><p>Jasmine is an experienced freelance writer, editor, and proofreader. For the past two years, she has been working for the fiercely independent publishing company, Synergetic Press, where her passions for ecology, ethnobotany, and psychoactive substances converge. She is passionate about the healing potentials of psychoactive plants and substances as well as their capacity to help us connect with the with the natural world around us. Her goal as writer, advocating psychoactive substances is to raise awareness of the socio-historical and cultural contexts in which these substances emerged in order to help integrate them into our modern-day lives in a safe, grounded and meaningful way. Her involvement with numerous publications, texts, and media have made her a trusted voice within the ecosystem.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*qpj67bJRb9mIj0emT7iRAQ.jpeg" /></figure><h3>Jesse Gould</h3><p>Jesse Gould is a pioneer in psychedelic therapies. As Founder and President of the Heroic Hearts Project, he has spearheaded the research and acceptance of ayahuasca therapy programs for military veterans. Jesse has raised over $200,000 in scholarships from donors including Dr. Bronner’s, partnered with the world’s leading ayahuasca treatment centers and is researching psychiatric applications with the University of Colorado Boulder and the University of Georgia. His mission is to help military veterans struggling with mental trauma and spread awareness of the benefits that ayahuasca therapies offer as an alternative treatment to pharmaceuticals. Jesse has spoken globally about the benefits of psychedelics on mental health and has been recognized as one of the Social Entrepreneurs To Watch For In 2020 by Cause Artist.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*8sQHxU8gkXvWruXaAqvPsA.jpeg" /></figure><h3>Joe Rogan</h3><p>Joe Rogan is an American comedian, podcast host, and mixed martial arts color commentator. Joe frequently interviews important psychedelics experts on his podcast, which has been ranked as one of the most popular in the world for the past decade. Many of his guests have subsequently gained significant traction from new audiences who are learning about psychedelics, mental health, and the role of plant medicines in modern society.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/588/1*5aGZGlrhJ3vEBN6pu5lTew.jpeg" /></figure><h3>Journey Colab</h3><h4>Sutton King, Jennifer Pisansky</h4><p>Journey Colab is developing FDA-approved, psychedelic therapies, starting with synthetic mescaline. They are pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities, and are working to build a portfolio of plant-identical compounds. In addition to drug development, they will partner with therapists to build and support locally-owned centers that can best serve their communities.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/836/1*F6RFlE3z599rHdVt1P3mKw.jpeg" /></figure><h3>JR Rahn</h3><p>JR is a former Silicon Valley tech executive who realized that transformational solutions to mental illness and addiction might lie in psychedelic medicines. He spent 2 years researching and began personally investing in psychedelic research through his investment company. JR partnered with drug development veteran Stephen Hurst to start Mindmed in 2019, assembling a leading clinical drug discovery and development team with vast experience conducting clinical trials and research on drug candidates derived from psychedelics. Before starting Mindmed, JR worked in market expansion and operations at Uber.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*2J5BxZXwyhEIqKhQlr3zlA.jpeg" /></figure><h3>Juliana Mulligan</h3><p>Juliana Mulligan has been an active member of the Ibogaine community for eight years and holds a B.A. in Psychology. She has worked in three Ibogaine clinics, trained under Dr. Andrew Tatarsky, and is a certified EMT. Under her current business Inner Vision Ibogaine, she works therapeutically with people supporting them in preparation for, and in integration after, Ibogaine treatment. Previously she was an opioid dependent person for seven years during which she served time in county jail, experienced overdoses, was homeless, and tried most mainstream forms of treatment. In 2011 with the help of Ibogaine she left opioids behind. Although her treatment was a success, the clinic was practicing unsafely and she narrowly survived six cardiac arrests and two weeks on a pacemaker in the ICU. This experience led her to focus much of her work on safety and proper clinical practice. She is also currently working to create new systems of accountability and responsibility amongst Ibogaine practitioners. She has been featured in Double Blind magazine, Woman’s Day magazine, and Psymposia.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*st6a4wz_UatX5bzYEibRww.jpeg" /></figure><h3>Julie Holland</h3><p>Julie Holland is an American psychopharmacologist, psychiatrist, and author. She is the author of five books, including Weekends at Bellevue: Nine Years on the Night Shift at the Psych ER, a memoir documenting her experience as the weekend head of the psychiatric emergency room at Bellevue Hospital in New York City. An advocate for the appropriate use of consciousness-expanding substances as part of mental health treatment, she is a medical monitor for MAPS studies, which involve, in part, developing psychedelics into prescription medication.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/677/1*-C7IZAmQtmQd48JmHhLuOg.jpeg" /></figure><h3>Kamya Buch</h3><p>Kamya founded the Psychedelic Society of India to bring more research-led dialogue around the huge potential of entheogenic medicines in trauma healing, de-addiction, consciousness expansion, and spiritual growth. In partnership with the Spirit Plant Medicine Conference (SPMC), the CS EVA increases visibility for talented women in psychedelics and cannabis who work tirelessly in behind-the-scenes roles, as well as newcomers who bring unique voice and talent to the community and/or who shine in spotlight positions.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/745/1*sVjPWCwkwTDOsxHnhexMjA.jpeg" /></figure><h3>Kevin Matthews</h3><p>Kevin Matthews spearheaded the campaign that decriminalized psilocybin mushrooms on May 7, 2019 in the City and County of Denver. He currently serves as the President of the Denver Psilocybin Mushroom Policy Review Panel and is the Founder of Vote Nature. He believes access to psychedelics is a human rights issue and that no person should be criminalized for their possession, use, or cultivation. He approaches his professional advocacy through a grassroots lens and works to bridge the needs and desires of the psychedelic community to the nation’s elected officials and policymakers in order to promote and ensure people-first psychedelic reform.</p><p>Kevin is a US Army Veteran and combines the skills he obtained while studying at the United States Military Academy with his 3+ years of experience as an advocate to advise campaigns and network internationally. He lives in Arvada, CO with his wife and 6 year old son, relies on safely exploring the innerverse with plant medicine, meditation, and mindfulness practice, and enjoys creating epic meals for his family and friends, fly-fishing, and hiking in the Colorado wilderness.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/376/1*Oz3ajAc01NHs_5ItQApcBA.jpeg" /></figure><h3>Lucid News</h3><p>Lucid News provides informed, honest and transparent journalism that covers the growing integration of psychedelics into society and their broad implications for human wellness. Founded by longtime participants of psychedelic communities who bring discernment and a healthy skepticism to their work, they offer news and opinion from a wide range of perspectives to help readers navigate this pivotal moment of innovation and transformation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/440/1*NPdVq8YqrcLGSGgzv-Y7Xw.jpeg" /></figure><h3>Kufikiri Imara</h3><p>Kufikiri Hiari Imara was born and raised in Oakland, California. He grew up in an Oakland very different than the one we see today, it was an Oakland with a broader and more embodied sense of community. He grew up the youngest in a household with parents who are both Bay Area natives, both of them born in San Francisco. As well, both his parents growing up were active in the Civil Rights and Black Power Movements of a San Francisco of the 1960’s &amp; 70’s. He grew up in a home and a community environment that strongly emphasized social awareness and social responsibility. Play that forward to an older, wiser individual who unfolded his path through a love of the arts, and his own personal healing/spiritual journey. That path lead him to volunteer work with Green Earth Poets Society bringing poetry to incarcerated African-American youth. He is one of the early members of the Entheogen Integration Circle, a support group in NYC with a focus on marginalized communities within the psychedelic community. He is currently involved with Sacred Garden Community, having completed their facilitator’s workshop, which aids him in deepening his work as a ceremonial facilitator working with ethnically diverse communities. One of the reasons he got involved with the Decriminalize Nature Oakland (DNO) initiative was to support effective access. As the former head of the DNO committee focused on Outreach, Education, Access, &amp; Integration he worked to encourage broad access to the education and opportunity to profoundly change one’s life for the better through working with entheogens. Paying special attention to Oakland’s ethnically diverse and marginalized communities, he is actively working with individuals and organizations doing the work in these communities for a better tomorrow. Access has always been his message and was the focus of his talk when he spoke at the CIIS/Chacruna Symposium Cultural and Political Perspectives on Psychedelic Science, August 2018 in San Francisco. As well as his talk hosted by the San Francisco Psychedelic Society, March 2019. He continues to work towards accessible choices for ethnically diverse and marginalized communities in their ability to heal themselves.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/1*_CnFG3_c7YrH9z29zRAaww.jpeg" /></figure><h3>Kwasi Adusei</h3><p>Kwasi dedicates his work in the psychedelic movement to altering the stigma in mainstream channels by promoting the science, the healing potential of psychedelics, and civic engagement. He is the founder of the Psychedelic Society of Western New York and project manager for Psychonauts of the World, an initiative to share meaningful psychedelic stories, with the ultimate goal of publishing them in a book as an avenue to raise money for psychedelic research. He is also one of the administrators for the Global Psychedelic Network, a conglomerate of psychedelic groups and individuals from around the world. Born in Ghana and raised in the Bronx, New York, Kwasi hopes to bring psychedelic therapy to communities of color.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/480/1*K7yqS7NIFf_AIdMZnWYoBw.jpeg" /></figure><h3>Lia Mix</h3><p>Lia Mix, MS, MFT, is the founder and CEO of Enthea, a non-profit organization working to expedite health insurance coverage for psychedelic therapies. Lia is a licensed marriage and family therapist with a master’s degree in counseling and multicultural populations. She has over twenty years of diverse experience in the behavioral health field, including fifteen in managed care organizations. Lia earned her Certification in Psychedelic Therapies and Research (CPTR) Program from the California Institute for Integral Studies (CIIS) in 2016. She continues as an adjunct faculty for the CIIS CPTR program. Lia is a systems-thinker who has helped organize the emerging field of psychedelic medicine towards the integration of psychedelic-assisted therapy into the US healthcare system, including achieving insurance coverage post FDA-approval. Lia’s mission is safe, affordable access to PAT for all who can benefit. Her purpose is to create a more compassionate world. She is dedicated to a path of inner healing.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*zFQeGNStGd1HhlBSGbQi3A.png" /></figure><h3>Liana Sananda Gillooly</h3><p>Liana Sananda Gillooly the Development Officer for MAPS, and is a lifelong advocate for social justice, drug policy reform, ending war, and environmental protection. Liana has worked as a gallerist, art curator, event producer, and held management positions at Greenpeace and Essential Living Foods. She co-found the non-profit North Star, working to integrate psychedelic wisdom into emerging industry surrounding the field of psychedelics, and Auryn Project, non-profit incubator for organizations building equitable, affordable, and accessible psychedelic medicine for all. She has been a featured speaker at numerous events, lobbied Congress, lectured MBA students, given a TedX talk, and is a member of the Summit and TED communities. She a trained death midwife, vipassana meditator, and immersive artist.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/354/1*842_6eDamJoncFXi1hASYw.jpeg" /></figure><h3>Lucia Huang</h3><p>Lucia is the co-founder and CEO of Osmind, a Public Benefit Corporation (PBC) committed to improving mental health care for those who need it most. She previously worked to help find cures for ALS and Parkinson’s at Verge Genomics, an AI-driven neuroscience biotech startup. Lucia graduated Yale with a B.S. in Chemistry and earned an MBA at Stanford Graduate School of Business, where she was also awarded a Certificate in Public Management and Social Innovation. At Stanford, Lucia focused her studies on healthcare and co-led the GSB Healthcare Club.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*KcnbPa9QYF3mXlbm2-FeSA.png" /></figure><h3>Luis Tamani</h3><p>Luis Tamani is an artist from the Amazonian rainforest of Peru. Tamani first started exhibiting his art in the city of Iquitos in the Loreto region of Peru. His art represents and speaks to the fusion of human beings and the vegetal and animal kingdoms. He has since exhibited his work across Europe and is emerging world wide as a highly regarded visionary artist. His art is on display across Europe, the United States, South America and digitally across the world.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/636/1*tidLtPBkLOcTRtDh1LbNCw.jpeg" /></figure><h3>Lynn Marie Morski</h3><p>Dr. Lynn Marie Morski is a physician, attorney, and lifelong “quitting” enthusiast. She practices medicine at the Veterans Administration and shares her love of strategic quitting through speaking, coaching, and her podcast, Quit Happens. Dr. Morski is also the President of the Psychedelic Medicine Association, a society of physicians, therapists, and healthcare professionals dedicated to advancing education regarding the therapeutic uses of psychedelic medicines.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*ATGlv6pITJJ63_DfLS7xIA.jpeg" /></figure><h3>Manuela Mahua</h3><p>Maestra Manuela comes from a long-standing and well-respected family lineage of Shipibo healers in the Ucayali region of the Peruvian Amazon. She is 70 years old with nearly 50 years of experience working with the medicine. She began drinking Ayahuasca with her father at age 13. Even today she heals and teaches, both Shipibo and foreigners, and she continues to undertake diets to learn more and gain more healing power. She has a vast knowledge and understanding of the natural pharmacy. Manuela is an incredibly generous and positive force, and in each ceremony she always makes sure to work on each participant individually in ceremony through singing her incredible variety of healing songs (ikaros).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Wj9KBGshqluUS9b9wz729A.jpeg" /></figure><h3>Mareesa Stertz</h3><p>Mareesa Stertz is an LA-based Director/DP and who’s spent much of the last decade shooting documentaries unraveling the impact of emotional experiences on the psyche. Her quest has taken around the world, filming the stories of shamans in Peru to holy men in India. She programs speakers and events at psychedelic salons and has screened her work at numerous conferences internationally. Her films have ‘gone viral’ and been featured by Viceland, NBC Universal, 60SecDocs, IFC, SPIN, Participant Media, and at film festivals around the world.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*e10vQkUtwpFyqegKM7REKg.jpeg" /></figure><h3>Matthew Johnson</h3><p>Matthew W. Johnson, Ph.D., is Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine. He is one of the world’s most published scientists on the human effects of psychedelics. Dr. Johnson earned his Ph.D. in experimental psychology at the University of Vermont in 2004, and has published 120 peer-reviewed articles. Working with psychedelics since 2004, Dr. Johnson published psychedelic safety guidelines in 2008, helping to resurrect psychedelic research. As Principle Investigator he developed and published the first research on psychedelic treatment of<br>tobacco addiction in 2014. Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. His 2018 psilocybin abuse liability review recommended placement in Schedule-IV upon potential medical approval. He is Principle Investigator on funded studies investigating<br>psilocybin in the treatment of opioid dependence and PTSD, and LSD in the treatment of chronic pain. In psychedelic research he also published the first blinded research showing effects of salvinorin A, and research examining psychedelic effects on mystical experience, personality change, meditation, and naturalistic addiction recovery. Dr. Johnson is also known for his behavioral economics research, including decision-making underlying addiction, tobacco regulatory science, and drug effects on sexual<br>risk behavior. He has published studies on nearly all psychoactive drug classes. Dr. Johnson was 2019 President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association, and is the 2020–2021 President of the International Society for Research on Psychedelics. He has received continuous NIH funding as Principal Investigator since 2009. He has reviewed for journals and has served as guest editor on special issues on psychedelics in two peer-reviewed journals.<br>Dr. Johnson has reviewed grants for NIH, NSF, the US Military, and multiple governments outside of the USA. He has provided invited presentations in 13 nations. Dr. Johnson has been interviewed widely including by Anderson Cooper on 60 Minutes, Fox Business News, CNN, NPR, BBC, New York Times,<br>Washington Post, Wall Street Journal, and Michael Pollan.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/232/1*3owpFuTzr0PDKAKgxWJTtQ.jpeg" /></figure><h3>Mendel Kaelan</h3><p>Mendel is the founder and CEO of Wavepaths, a company that researches and develops methods that leverage the psychotherapeutic potential of music. Prior to Wavepaths, Mendel worked as a PhD student and post-doctoral neuroscientist at Imperial College London, where he pioneered a central of role of music in psychedelic therapies. He consults on the therapeutic use of music, publishes and speaks frequently on this topic, and has been featured in Nature News, San Francisco Chronicles, Vice Motherboard, Rolling Stone, TEDx, Wired, GQ, Even Standard a.o. Mendel lives and works in London (UK).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/275/1*mFYnUKMQzd1_Pf6QC1AbNA.jpeg" /></figure><h3>Michael Pollan</h3><p>Michael Pollan is an American author and journalist, who is currently the Knight Professor of Science and Environmental Journalism at the UC Berkeley Graduate School of Journalism. Michael’s New York Times #1 selling How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence has exposed large new audiences to the world of psychedelics. Michael has also appeared on dozens of media outlets, including Tim Ferriss and Joe Rogan.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*XCikE2DramP4KUfiYQGfuQ.jpeg" /></figure><h3>Mike Margolies</h3><p>Mike is the Founder of <a href="https://psychsems.com/">Psychedelic Seminars</a>, an educational conversation series deepening awareness of the benefits, risks, and complexities of psychedelics. Mike is also one of the Co-founders of Crypto Psychedelic and has helped to tie many of the formerly disconnected Psychedelic Societies together.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*n8DVH-5-aZI1NPPtQOAM4Q.jpeg" /></figure><h3>Mike Tyson</h3><p>In 2019, boxing legend, Mike Tyson, smoked a drug derived from toad venom (5-MeO-DMT). Ever since this earth-shattering experience with the psychedelic drug, Tyson has leveraged his large following to help advocate for psychedelic experiences in several interviews and podcasts. Tyson says his 5-MeO-DMT experience is what led him into becoming a more open person and is what ultimately inspired his return to boxing. Tyson and his partners recently formed The Ranch Companies, which owns and operates Tyson Ranch, The Ranch at Palm Desert, the KIND Music Festival.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/333/1*x0qGrFnU9HVUeqd9H5DQqg.jpeg" /></figure><h3>Mohawk Greene</h3><p>“Phoenix AKA Mohawk “”The Rebel Educationist”” (they/them: formerly known as Mohawk the Educator) is a black, trans educator and technologist, who leverages vast multimedia and platforms to do advocacy and outreach for people who use drugs. They provide education and alternative, radical perspectives about drugs, drug policy, and related topics through a comedic, restorative lens. They are a harm reductionist, drug policy reform advocate, activist, and community organizer that participates in mutual aid. They are also a skilled technologist, writer, and educator.</p><p>Phoenix is the technical program manager at Next Distro, a Youth RISE board member, and the regional outreach coordinator and president of New York DanceSafe, Inc., a nonprofit that started off as DanceSafe’s New York-based Chapter. As a longstanding member of music and nightlife communities, they organize and oversee harm reduction and health-and-safety outreach, centering the marginalized, in these communities within the northeast. They have collaborated with global harm reduction agencies such as ANKORS, Safe ’n’ Sound, and Unity and organizations such as the Drug Policy Alliance and Harm Reduction Coalition. Phoenix gives lectures at Berkeley College and spreads awareness as “”The Rebel Educationist”” on multiple social media platforms.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/959/1*OZsYCGDhbUG9cx8ONdOd6w.jpeg" /></figure><h3>Molly Maloof</h3><p>Dr. Molly Maloof is a lecturer within the Wellness Department of the Medical School at Stanford University. Since 2012 she has worked as an independent advisor or consultant to over 45 companies throughout the world needing help with clinical strategy, scientific marketing, medical &amp; market research, &amp; product development. She is also the co-host of Psychedelic News Hour, a clubhouse room dedicated to bringing together the brightest minds in the burgeoning field of psychedelic medicine.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/320/1*j09KIc3g2EPBcD9VDNFnEQ.jpeg" /></figure><h3>Dr. Monnica T. Williams</h3><p>Monnica T. Williams, Ph.D., ABPP, is a licensed clinical psychologist and associate professor at the University of Ottawa in the School of Psychology, where she is the Canada Research Chair for Mental Health Disparities. She is the foremost leader in psychedelics for the healing of racial trauma, an area of study that could result in healing for hundreds of millions of individuals worldwide. Dr. Williams has published over 100 book chapters and peer-reviewed articles, focused on anxiety-related disorders and cultural differences.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/225/1*cKYT5BjzCslJ9l2py3QQlA.jpeg" /></figure><h3>Natalie Ginsberg</h3><p>Natalie is the Director of Policy &amp; Advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), where she works to disentangle science from political partisanship, and to create safe, equitable and regulated access to psychedelics, and all criminalized substances. She is also partnering with Israeli and Palestinian colleagues to develop a psychedelic peace-building study. Natalie is particularly inspired by psychedelics’ potential to assist in healing intergenerational trauma, for building empathy and community, and for inspiring creative and innovative solutions. Before joining MAPS in 2014, Natalie worked as a Policy Fellow at the Drug Policy Alliance, where she helped legalize medical cannabis in her home state of New York, and worked to end New York’s race-based marijuana arrests. Natalie received her B.A. in history from Yale, and her master’s of social work (M.S.W.) from Columbia.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/929/1*pNHQiwF8P-wOjZcDgG5SSg.png" /></figure><h3>Northstar</h3><h4>Kat Conour, Dave McGaughey, Liana Gillooley, Shirelle Noble, Tim Chang</h4><p>Northstar has been one of the most influential organizations in leading the conversation around what a “psychedelic business” should look like. Their dialogues around ethics within the psychedelics ecosystem, the North Star pledge, and the <a href="https://hereandnowstudios.com/we-will-call-it-pala">We Will Call it Pala</a> story have paved the road for many crucial conversations at a time where psychedelic capitalism is only gaining greater traction.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/767/1*-I4iPn0VjOYBMfX5_QtObA.jpeg" /></figure><h3>Oregon Initiative</h3><p>Tom Eckert, Sheri Eckert (Posthumous), Sam Chapman</p><p>Those involved in the Oregon Initiave helped pass Measure 109, allowing for the manufacture, delivery, administration of psilocybin at supervised, licensed facilities. Their efforts laid the groundwork for policy across the country, and will help to create great change in the public perception of psychedelic therapies.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/845/1*UeFjMGDzumpV7qVf8rwhuQ.jpeg" /></figure><h3>Paul Austin</h3><p>Paul F. Austin is a pioneer in the 21st century responsible use of psychedelics for healing, leadership and personal transformation. He has been featured in BBC, Forbes, and Rolling Stone for his accomplishments in entrepreneurship regarding social awareness towards the benefits of microdosing psychedelics. Paul is the author of the book “Microdosing Psychedelics: A Practical Guide to Upgrade Your Life” and the founder of two companies in the emerging psychedelic space, Third Wave and Synthesis.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/438/1*XisRJaFmLoSQMOzP5CqBLQ.jpeg" /></figure><h3>Paul Stamets</h3><p>Paul Stamets is an American mycologist and entrepreneur who sells various mushroom products through his company, Fungi Perfecti. He is an author and advocate of medicinal fungi and mycoremediation. Written in 2019, Fantastic Fungi: How Mushrooms Can Heal, Shift Consciousness &amp; Save the Planet, Paul has had significant impact in the adoption of psychedelic medicines.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/200/1*XJq1LICXZA5971GQpGqvlw.jpeg" /></figure><h3>Plant Medicine Law Group</h3><p>The Plant Medicine Law Group is working to expand equitable and legal access to plant medicine and help companies in the psychedelic and cannabis industries succeed in a complex, emerging market. They provide strategic expertise to successfully launch, fund and grow psychedelic businesses.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*n5RMeVKnoCngLSRcSJHiRw.jpeg" /></figure><h3>Psychedelics Today</h3><p>Psychedelics Today is a news source dedicated to exploring and discussing the important academic, scientific and other research in the field of psychedelics. They show how psychedelics and other non-ordinary states of consciousness relate to the human potential as well as the healing potential that they can foster.</p><h3>Psychedelic Societies</h3><p>Psychedelic societies have been the foundation of harm reduction, community support, and shared psychedelic wisdom in the underground long before the psychedelic renaissance began to take bloom. Their devotion to helping local communities integrate, understand, and be supported through psychedelic journeys has created an all around safer ecosystem and has allowed for harm reduction, set and setting, and integration education to be the foundational layers of the changes that are happening above ground today.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/320/1*OTugiWlGOdKE16lKyeq8-g.png" /></figure><h3>Psymposia</h3><p>A news outlet known for their fierce independent journalism, scathing critiques of psychedelic influencers, and combative stance towards all things capitalism, Psymposia has continued to be the center point of thought provoking content as well as a polarizing approach to psychedelic media creation.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*i1p7D1CU5fOSNDlGXlLlIw.jpeg" /></figure><h3>Rachel Yehuda</h3><p>Rachel Yehuda is a professor of psychiatry and neuroscience, the Vice Chair for Veterans Affairs in the Psychiatry Department, and the Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*do7eM9Wotovq0TSBeV19hw.jpeg" /></figure><h3>Richard Skaife</h3><p>Richard is a founding partner at The Conscious Fund and a board member of MicroDose and Hive Bio. A twenty year veteran of technology operating and investing. His sole focus is now plant based investing and it’s enablement by technology.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/350/1*mZcAd1qccl8y0Babok9Qag.jpeg" /></figure><h3>Rick Doblin</h3><p>Rick Doblin, Ph.D, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), which he founded in 1986. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick has appeared on countless media outlets and has been a speaker at dozens of major events, resulting in MAPS raising tens of millions of dollars to further develop the future of psychedelic studies.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/533/1*nsj3UYz5YhfG8SFpKHgbHQ.jpeg" /></figure><h3>Rick Strassman</h3><p>Rick Strassman is an American clinical associate professor of psychiatry at the University of New Mexico School of Medicine. He has appeared on a variety of media outlets, including The Joe Rogan Experience, and is the author of DMT: The Spirit Molecule, which summarizes his academic research into DMT.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ibY-PaoEO0saaCt7e5ji5Q.jpeg" /></figure><h3>Rob Laurie</h3><p>“Robert W.E. Laurie is an international lawyer, qualified in England and called to the British Columbia Bar. Robert founded AD LUCEM LAW CORPORATION in Vancouver in 2013 and his legal practice focuses on commercial business, government regulatory and constitutional issues surrounding cannabis and psychedelic plant medicines.</p><p>Robert serves as a Board Advisor to the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada, Steve DeAngelo’s Last Prisoner Project, SPORE Denver and a Legal Advisor to the Heroic Hearts Project UK. Robert is one of the Founding Partners with Dr. Dennis McKenna of the McKenna Academy of Natural Philosophy. He serves as a Director with Jay DeMerit and Ashleigh McIvor’s Rise and Shine Foundation and Rex Weyler’s Ecuador Amazon Restoration Project. Robert holds an M.A. (Hons) Juris from the University of Oxford (St. Edmund Hall) and B.A. (Hons) in Political Science and International Relations from the University of British Columbia.”</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*mHObf3zh29qvUcJeVjiYLw.jpeg" /></figure><h3>Robin Carhart Harris</h3><p>Dr Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, Robin has designed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, an ongoing trial<br>comparing psilocybin with escitalopram for major depressive disorder and a multimodal imaging study in healthy volunteers receiving psilocybin for the first time. Robin founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind in the world.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/300/1*PKBzntdJcDpweH0elPD6bQ.jpeg" /></figure><h3>Roland Griffiths</h3><p>Roland Redmond Griffiths is an American psychopharmacologist. He is professor of neuroscience, psychiatry and behavioral science, and director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*eNS74NWSuzjhkA9kH7TU-A.jpeg" /></figure><h3>Ronan Levy</h3><p>Ronan Levy is the founder of Field Trip Ventures, a psychedelic therapy clinic with several locations in Canada and the US. In 2018, he cofounded Grassfed Ventures Inc., a venture capital and advisory firm focused on the cannabis, life sciences, and eSports industries.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/428/1*X1XdPbxxTHyI-LVKMRIDHA.jpeg" /></figure><h3>Rosalind Watts</h3><p>Dr. Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London. She is interested in the theme of ‘connectedness to Self, others, and the world’ as an important aspect of psychedelic treatment.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/800/1*8Thgr9K1BWMnYXpNlIlSzw.jpeg" /></figure><h3>Saad Shah</h3><p>Sa’ad Shah is the co-founder and managing partner of Noetic, a venture capital firm that seeks to invest in emerging and early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies around the world. Sa’ad has spent the last 22 years in capital markets and asset management industry with a focus on alternative investment strategies. Prior to co-founding Noetic, Sa’ad was a managing director at The Carlyle Group. Sa’ad is also a the co-founder and managing partner at Grey House Partners, venture partner at Alpha Partners, an affiliate partner at Lindsay Goldberg LLC, and a venture advisor to Learn Capital LLC.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*Bm8Bs04x8y3rf251-a0Vqw.jpeg" /></figure><h3>Sandor Iron Rope</h3><p>Sandor Iron Rope is an enrolled member of the Oglala Lakota Oyate (Oglala Sioux Tribe) from Pine Ridge South Dakota. He received his baccalaureate in Human Services and American Indian Studies from the Black Hills State University in 2007. He has worked for Sanford Health Research as a data collector on community health disparities from 2007. In 2013 started working with the Special Diabetes Program for Indians as a Health technician/fitness trainer. He has donated most of his life to various Native American Churches, Family and Wellness nonprofit organizations. He has supported Tribes throughout Canada and Mexico on religious preservation. He has served as the Chairman for the Native American Church of South Dakota and the Native American Church of North America. He continues to support the conservation efforts of the sacred plant of peyote. He continues to bridge communities and promote healing with his involvement in the Fatherhood Initiatives, Cultural Educational activities.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/211/1*SgfEqEz1oPLgoB02poxpXw.jpeg" /></figure><h3>Sara Reed</h3><p>Sara received her undergraduate degree in Bioethics and Philosophy from the University of Louisville in Kentucky, and her M.S. in Marriage and Family Therapy from Valdosta State University in Georgia. Prior to her move to Connecticut, she worked as a licensed marriage and family therapist associate at the Behavioral Wellness Clinic in Louisville. Sara Reed is a Marriage and Family Therapist at Behavioral Wellness Clinic in Tolland, CT. She is also a Study Therapist on the Psilocybin-Assisted Therapy research study for Major Depression at Yale University. As a socially-minded therapist, Sara works to advance health equity and upward social mobility for Black Americans.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/286/1*XBFKgusVWAnG3Dgfp-iX2A.jpeg" /></figure><h3>Shlomi Raz</h3><p>Shlomi is the founder and CEO of Eleusis. Since founding Eleusis in 2013, Shlomi has overseen the company’s corporate and clinical development efforts. Prior to founding Eleusis, Shlomi was a Managing Director at Goldman Sachs, and held a similar role at JPMorgan where he began his corporate career. Shlomi holds an MA in psychology from New York University and a BS in finance from Georgetown University.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*qITklE5iQ0zKvGz0VcmMFg.jpeg" /></figure><h3>Simeon Schnapper</h3><p>Simeon is a life-long student of Psychedelics and has a keen awareness of the cultural regulatory and the nascent venture landscape of the mushrooming industry. He has traveled the globe participating in psychedelic conferences to living with indigenous communities. He co-founded the High Art Collective in 2008 the world’s first Psychedelic Art Gallery and MMJ Dispensary praised as a paradigm shift at the very beginning of the end of prohibition. Simeon advises several psychedelic startups, is a founding partner at JLS a plant medicine fund, is an Aspen Institute Fellow and a member of NYMS (New York Mycology Society).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*YzGwK_fv5yF66vAWdosisA.jpeg" /></figure><h3>Sophia Rokhlin</h3><p>Sophia Rokhlin is an author, speaker and nonprofit organizer dedicated to supporting the conservation of Indigenous wisdom and territories. She currently serves as Technical Secretariat of the Amazon Emergency Fund.She holds a BA in Anthropology and Religious Studies from The New School and a M.Sc. in Ecological Economics from the Institute of Environmental Science and Technology at the Autonomous University of Barcelona. She has worked with the Environmental Justice Atlas mapping grassroots activism related to commodity extraction in the Americas. She previously served as a Program Coordinator at the Chaikuni Institute, supporting regenerative agriculture in the Peruvian Amazon.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/700/1*S8FE7AiCJas_EbeqMfisCQ.jpeg" /></figure><h3>Stanislav Grof</h3><p><strong>Stanislav Grof,</strong> M.D., is a psychiatrist with over 60 years of experience in research of non-ordinary states of consciousness and one of the founders and chief theoreticians of transpersonal psychology.</p><p>Dr. Grof’s early research in the clinical uses of psychedelic substances was groundbreaking and highly influential. In 1969, Dr. Grof became Assistant Professor of Psychiatry at the Johns Hopkins University and is currently Professor of Psychology at the California Institute of Integral Studies (CIIS) in the Department of Philosophy, Cosmology, and Consciousness.</p><p>He has written over 160 articles and books, including LSD: Gateway to the Numinous; Beyond the Brain; LSD Psychotherapy; The Cosmic Game, and many more.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/632/1*8SgnI36wBcsvPO7mTOJ20Q.jpeg" /></figure><h3>Tania de Jong</h3><p>Tania de Jong is an award-winning social entrepreneur, philanthropist and angelic soprano. She is the Co-Founder (with her husband Peter Hunt) and Executive Director of Mind Medicine Australia, a registered charity acting as the central node for regulatory-approved and research-backed psychedelic medicines to assist with the treatment of mental illness in Australia.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*P-nwG5cKAzp3OoFYmhMU9g.jpeg" /></figure><h3>Tim Ferris</h3><p>Tim Ferriss is an American entrepreneur, investor, author, and lifestyle guru. Through his social media outlets, podcast, blog, and interviews, Tim has educated hundreds of millions of people about psychedelics. He has also donated significant sums of money to several different research centers and non-profits, and has influenced the funding of several large psychedelics initiatives.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/500/1*t-NwB_2jL-lXCb_h1NjF-A.jpeg" /></figure><h3>Todd Shapiro</h3><p>Todd Shapiro, after being a top rated Radio Show host &amp; a brilliant Marketing Entrepreneur with over 20 years of experience, has recently moved on from mainstream media to concentrate his efforts on being the CEO of Red Light Holland.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/840/1*Bb2Aeso10Q3k6qjeQDk7lw.jpeg" /></figure><h3>USONA</h3><p>Usona Institute is a 501(c)(3) non-profit medical research organization dedicated to supporting and conducting pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other consciousness-expanding medicines. Our focus is on alleviating depression in people for whom current medical treatments fall short in offering relief and a better quality of life.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/400/1*aveMsmsizhdkpOATtMrJ_w.jpeg" /></figure><h3>Vine Ventures</h3><p>Vine Ventures is an NYC-based, early stage, software-focused venture capital fund that invests in the U.S., Latin America, and Israel. Jesse Hudson is an anthropologist and attorney working in the psychedelic space since 2007. He is a member of the Chacruna Council for Protection of Sacred Plants, board member at Sage Institute for Psychedelic Therapy, advisor to Enthea Health, and mentor in the SSDP Psychedelic Pipeline. He has worked with the Matsigenga and the Shipibo-Conibo tribes in the Peruvian Amazon, published peer-reviewed papers on the legal frameworks for psychedelics, and counseled several psychedelic-assisted therapy clinics. He helped ICEERS launch and develop the Ayahuasca Defense Fund. Ryan Zurrer is a venture investor and entrepreneur for 16 years. He has also been an avid biohacker and early contributing member to the Quantified Self Movement in the early 2000s.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/395/1*QeiSWeNZ50qXW-1d_7DHvw.jpeg" /></figure><h3>Yann Guignon</h3><p>Originally from France from a multicultural family background, Yann has spent over 10 years practicing and studying the traditions of the Gabonese Forest people. As a direct result of his work, iboga was integrated into the Nagoya Protocol (ratified by Gabon in 2012) which provided a major international legal instrument for the protection of this tree and the traditional knowledge surrounding it. The Gabonese Minister of Culture recognized Yann Guignon as a benefactor of Gabon’s Cultural Heritage and gave him the mandate to represent Gabon at the 4th international conference on iboga.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/300/1*g1SJmL06CAPo3RJ6Jk7Seg.jpeg" /></figure><h3>Yarelix Estrada</h3><p>Yarelix Estrada straddles many drug worlds. With a Masters in Public Health from Johns Hopkins, she works in New York City as a city research scientist studying harm reduction. On the activism side, she founded a chapter of Students for Sensible Drug Policy. On the nightlife side, she’s volunteered as a lead for DanceSafe in DC. As an organizer, she’s currently the head of the New York City Psychedelic Society as well as an organizer of the first People of Color and Psychedelics conference in Washington D.C. On social justice, she gives lectures about issues like psychedelic intersectionality and treating trauma in underrepresented populations with psychedelics. Today, she discusses working with people in drug crisis, the importance of harm reduction in different fields and how race and income can mark the difference between a psychedelic dream and a paranoid police-state nightmare.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1q66NDwBQ1dZoCdO5Q5rcg.jpeg" /></figure><h3>Zach Haigney</h3><p>The Trip Report is a newsletter for the builders of the emerging psychedelic ecosystem that covers the business, policy, and impact of psychedelics. Every Monday, Wednesday, and Friday, Zach writes an email newsletter about what’s happening in psychedelics that actually matters, and what it means. He picks out the news and ideas that you don’t want to miss in all the noise and give them context and analysis. Zach’s been writing it since May of 2019.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/677/1*n4C3aaBqsvhDFro6DNlfbQ.jpeg" /></figure><h3>Zoe Helene</h3><p>Zoe Helene is an artist, environmentalist, and cultural activist best known for women’s empowerment and sacred plants such as cannabis, ayahuasca, peyote, and psilocybin mushrooms — our co-evolutionary allies — and for PSYCHEDELIC FEMINISM, a concept she originated and a term she coined and popularized in support of women in psychedelics.</p><p>Again, we understand that we are not all-seeing and that there are individuals who deserve to be on this list as well. We started with close to 250 names and had to narrow it down. We will continue to find better ways of identifying influence and impact within this space and improving our list in the years to come.</p><p>For now, thank you for the all the work contributed and to all the people that have helped guide us in our work to date. We look forward to intersecting, pushing for equity, justice, peace, and continuing to build community together.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6fa429968b10" width="1" height="1" alt=""><hr><p><a href="https://medium.com/psychedstudio/100-most-influential-people-in-psychedelics-6fa429968b10">100 Most Influential People in Psychedelics</a> was originally published in <a href="https://medium.com/psychedstudio">PSYCHEDSTUDIO</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Psychedelic Startups & Investors: Regenerative Business Models for Every Organization]]></title>
            <link>https://medium.com/psychedstudio/psychedelic-startups-investors-regenerative-business-models-for-every-organization-c60531e3b342?source=rss----64102bad6192---4</link>
            <guid isPermaLink="false">https://medium.com/p/c60531e3b342</guid>
            <category><![CDATA[alternative-investments]]></category>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[psychedelics]]></category>
            <category><![CDATA[investment]]></category>
            <dc:creator><![CDATA[Marik Hazan]]></dc:creator>
            <pubDate>Wed, 09 Dec 2020 16:56:32 GMT</pubDate>
            <atom:updated>2022-12-03T01:06:11.406Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Written by </em><a href="https://medium.com/u/37667de7ae64"><em>Magenta Ceiba</em></a><em> and Marik Hazan</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*cHneswPgQcCukAmujofYhg.png" /></figure><p>Many people in the psychedelic movement are passionate about ethical development of companies. As the business landscape in this field explodes, the following resources are intended to give the reader solid alternatives to traditional venture capital and strictly for-profit or non-profit business models. In some cases these models outperform traditional companies in competitiveness on the market, and they de-risk investment. The following is not investment advice, however it provides the reader with examples of the diverse business entity types available today.</p><p><em>The phrase “regenerative business” broadly refers to ways of working and designing companies that create the conditions for more life, more diversity, and more anti-fragility. While more commonly known business approaches such as B Corporations and the notion of “triple bottom line” exist, the following structures create an even more stable foundation of shared ownership and social equity. For many, tripping comes with a deepened social conscience and connection with nature. These models provide pathways to integrate these value sets into the way we do business.</em></p><h3><strong>Multi-stakeholder Cooperative</strong></h3><p>In a multi-stakeholder cooperative, patients, clinicians, suppliers and investors have ownership stake in a company. This ensures that the business stays accountable to the needs and concerns of groups who are affected by the company’s decisions. It diversifies who shares in the profits of a company. Lastly, it creates long-term equitable economies.</p><p><strong>Examples and Resources</strong></p><ul><li><em>Solidarity as a Business Model: A Multi-Stakeholder Cooperatives Manual, by Margaret Lund: </em><a href="https://community-wealth.org/content/solidarity-business-model-multi-stakeholder-cooperatives-manual">https://community-wealth.org/content/solidarity-business-model-multi-stakeholder-cooperatives-manual</a></li><li>Definition from the Urban Sustainability Directors Network’s Sustainable Consumption Toolkit: <a href="https://sustainableconsumption.usdn.org/initiatives-list/multi-stakeholder-cooperatives">https://sustainableconsumption.usdn.org/initiatives-list/multi-stakeholder-cooperatives</a></li><li>Definition from Grassroots Economic Organizing: <a href="https://geo.coop/content/rise-multi-stakeholder-cooperatives">https://geo.coop/content/rise-multi-stakeholder-cooperatives</a></li><li>Sustainable Economies Law Center: <a href="https://www.theselc.org/">https://www.theselc.org/</a></li></ul><h3><strong>Worker-Owned Cooperative</strong></h3><p>In a worker-owned cooperative, the people running the business own it. Cooperatives are over <a href="https://en.wikipedia.org/wiki/Cooperative#:~:text=Cooperative%20businesses%20are%20typically%20more,business%20ownership%20models%20(41%25).">twice as likely</a> to survive the first five years compared to traditional companies, and they are resistent to economic recessions and downturns. Typically this type of business can accept investment money, however investors are not given voting privileges. There is a one-person, one-vote principle. One of the seven cooperative principles is “Concern for Community,” which stipulates that cooperatives work for the sustainable development of their communities through policies supported by the membership.</p><p><strong>Examples and Resources</strong></p><ul><li>Cooperation Jackson: <a href="https://cooperationjackson.org/">https://cooperationjackson.org/</a></li><li>New Economy Coalition: <a href="https://neweconomy.net/">https://neweconomy.net/</a></li><li>7 Cooperative Principles: <a href="https://www.electric.coop/seven-cooperative-principles%E2%80%8B/">https://www.electric.coop/seven-cooperative-principles</a></li><li>U.S. Federation of Worker Cooperatives: <a href="https://www.usworker.coop/home/">https://www.usworker.coop/home/</a></li><li>International Cooperative Alliance: <a href="https://www.ica.coop/en">https://www.ica.coop/en</a></li><li>Mondragon is a federated cooperative based in the Basque region of Spain: <a href="https://en.wikipedia.org/wiki/Mondragon_Corporation">https://en.wikipedia.org/wiki/Mondragon_Corporation</a></li><li><em>Everything for Everyone</em> by Nathan Schneider: <a href="https://nathanschneider.info/books/everything-for-everyone/">https://nathanschneider.info/books/everything-for-everyone/</a></li></ul><p><strong>Purpose Company</strong></p><p>Purpose Companies provide a legal pathway to keep a company purpose-driven in perpetuity. This avoids the high likelihood of being “sold for parts” as soon as investors can cash out of it. This is a common founder woe with Silicon Valley-style venture capital. Steward ownership is a related concept, where profits serve a purpose.</p><ul><li>Purpose Ventures is an investment community focused on this type of business: <a href="https://purpose-economy.org/en/venture/">https://purpose-economy.org/en/venture/</a>. Their homepage hosts a free-to-download book called <em>Steward Ownership: Rethinking Ownership in the 21st Century, </em>available at <a href="https://purpose-economy.org/en/">https://purpose-economy.org/en/.</a></li><li>Alternative Ownership Advisors hosts a listing of related models: <a href="https://www.alternativeownershipadvisors.com/faqs">https://www.alternativeownershipadvisors.com/faqs</a></li><li>Earth Equity is innovating a usage of Purpose Trust where a natural land feature such as a river or a mountain can have personhood and hold assets, managed by the Indigenous people of that place to decide what environmental and social initiatives shall be carried out to nurture the life of that place and all who dwell in relation with it.</li></ul><p><strong>Capped Return Investment and Revenue Sharing</strong></p><p>These are two of the most popular investment methods for values-driven startups or companies who are ok with forgoing VC unicorn status. In this type of investment, an investor will agree to “capped” returns, such as 1.5–2x their original investment amount. With <em>revenue sharing</em>, these returns are given only as the company becomes profitable. This is an appropriate type of investment for a company that may have an unusually slow path to profitability, or one that is concerned about granting too much power to investors who aren’t closely connected with the company’s operations or the communities it serves. Revenue sharing is sometimes also called royalty financing. This type of investment is being deployed frequently in local food movements and in developing world social enterprises where local community ownership, and healthy local economies, are the priority.</p><p><strong>Examples and Resources</strong></p><ul><li>“Q&amp;A with Slow Money Investor, Arno Hasse”: <a href="https://medium.com/@SlowMoneyNYC/q-a-with-slow-money-investor-arno-hesse-ae8ad8d7b2e4">https://medium.com/@SlowMoneyNYC/q-a-with-slow-money-investor-arno-hesse-ae8ad8d7b2e4</a></li><li>Hacking Capitalism with Capped Returns by Joshua Vial of Enspiral: <a href="https://joshuavial.com/capped-returns/">https://joshuavial.com/capped-returns/</a>.</li></ul><p><strong>Platform Cooperative</strong></p><p>A platform cooperative is a digitally-based company owned by contributors. Platform cooperatives can be owned by workers, users, or both. Rather than giants like Uber or Airbnb where profits go mostly to executives and shareholders, platform cooperatives benefit workers and the communities who use the services. This type of business is good for psychedelic health data aggregation, services such as a directory to find a trip sitter, delivery services, and more.</p><p><strong>Examples</strong></p><ul><li><a href="https://www.savvy.coop/">Savvy</a> — patient-owned health data site</li><li><a href="https://www.stocksy.com/">Stocksy</a> — artist-owned stock photography site</li><li><a href="https://fairbnb.coop/">Fairbnb</a> — accommodations platform that promotes and funds local initiatives and projects with 50% of the platform fees</li></ul><p><strong>Education and incubators</strong></p><ul><li><a href="https://platform.coop/">Platform Cooperativism Consortium</a></li><li><a href="http://start.coop/">Start.coop</a></li><li><em>Ours to Hack and Own</em> edited by Trebor Scholtz and Nathan Schneider</li></ul><p><strong>Microenterprise</strong></p><p>With fewer than 9 employees, microenterprises can be good solutions for businesses such as medicine production, packaging, fungi-based soil amendments for cannabis, and more. They increase the number of good quality jobs, and they support distributed local manufacturing which can be good for the environment and local economies. Employees have the ability to create satisfying working environments. And lastly, microenterprises’ startup needs can often be met by peer-to-peer investing, since start-up capital needs are relatively low.</p><p><strong>Examples and resources</strong></p><ul><li>Cottage Food businesses. Some edible products may be eligible to start cottage food enterprises, depending on state laws: <a href="https://www.farmtoconsumer.org/cottage-foods-map/">https://www.farmtoconsumer.org/cottage-foods-map/</a></li><li>Investopedia’s definition of microenterprises and microfinance: <a href="https://www.investopedia.com/terms/m/microenterprise.asp">https://www.investopedia.com/terms/m/microenterprise.asp</a></li><li>Investibule, a fundraising platform for local and microenterprises: <a href="https://investibule.co/">https://investibule.co/</a></li><li>Fibershed textile producers are often microenterprises: <a href="https://fibershed.org/">https://fibershed.org/</a></li><li>Luna Vez farm and flower share, gardening across urban lots: <a href="https://lunavez.com/">https://lunavez.com/</a></li><li>MakerNet — 3D printing communities often work as microenterprises: <a href="https://www.makernet.work/">https://www.makernet.work/</a></li></ul><p><strong>Hybrid Entities</strong></p><p>In a hybrid entity, businesses have multiple arms that interact to build profit and accomplish missions. A corporation might have a for-profit arm, a set of impact businesses, and a philanthropic arm or DAF (donor-advised fund) to contribute to non-profit generating activities. Hybrid entities offer benefits such as: 1) Build and cycle capital according to your ethical compass. 2) Fund nonprofit initiatives efficiently without having to continually apply for grants. 3) Have clear legal pathways to diversify the purpose of your investments.</p><p>It’s important to set clear agreements and wise governance models with hybrid entities, because they can be used as tax shelters in ways that hoard capital and minimally accomplish social benefit.</p><p><strong>Examples and resources</strong></p><ul><li>ICV Group is an example of a hybrid entity ecosystem, with impact investment portfolios in different verticals, that each direct a percentage of profits into a philanthropic fund that allocates finances to projects that create systemic and sustainable change. <a href="https://www.icvgroup.org/">https://www.icvgroup.org/</a></li><li>Donor-advised funds allow donations to accrue interest in a pool, to be allocated to recommended grants over time. <a href="https://www.nptrust.org/what-is-a-donor-advised-fund/">https://www.nptrust.org/what-is-a-donor-advised-fund/</a></li><li>S.P.O.R.E., Society for Psychedelic Outreach, Research, and Education is a hybrid entity, where S.P.O.R.E. is a nonprofit, with a for-profit subsidiary company. <a href="https://www.thespore.org/">https://www.thespore.org/</a></li><li>LIFT Economy: <a href="https://www.lifteconomy.com/">https://www.lifteconomy.com/</a></li></ul><p><strong>Pooled Funds</strong></p><p>Multiple companies can contribute to a pooled fund to achieve shared goals. The fund itself can simply be an existing foundation, or it can be collectively managed through agreements. Types of things that pooled funds in the psychedelic industry might support include Indigenous leadership and sovereignty and BIPOC access to therapy. The emerging digital entity called a DAO, or decentralized autonomous organization, can be used to allocate capital to distributed initiatives, through sophisticated automation techniques such as drip feeds that go to specific working groups for research, or even a marketing team that services all the member organizations of the DAO.</p><p><strong>Examples and resources</strong></p><ul><li>Femtheogen is a democratic philanthropy collective that uses a participatory 9-month long cohort process for female leaders in the psychedelic movement to allocate funds toward projects and individuals that uphold feminine principles, and are at least 50% women-led. <a href="https://www.femtheogen.org/">https://www.femtheogen.org/</a></li><li>ARMI’s <a href="https://www.armiusa.org/">BioFabUSA</a> is an example of a consoritum where multiple types of business entities come together for a common goal. In this case, to research and manufacture engineered tissues.</li><li>Investment fund on Wikipedia: <a href="https://en.wikipedia.org/wiki/Investment_fund">https://en.wikipedia.org/wiki/Investment_fund</a></li></ul><p><strong>Community-Led Investing</strong></p><p>Involve your community in the decisions about what companies or services get funding, by allowing them to vote and deliberate. This has an advantage of starting a business off with a ready-made customer base, since it’s already known that there is demand for the product or service. It also supports longevity, because of the incentive to keep value circulating within a community rather than being extracted out of it.</p><p><strong>Examples and resources</strong></p><ul><li>WEPOWER: <a href="https://wepowerstl.org/">https://wepowerstl.org/</a></li><li>Participatory budgeting: <a href="https://en.wikipedia.org/wiki/Participatory_budgeting">https://en.wikipedia.org/wiki/Participatory_budgeting</a></li></ul><p><strong>Addendum:</strong> Dynamic Facilitation, an approach for conflict resolution in psychedelic communities and professional associations.</p><p>In contexts where there are opposing factions on an issue, or long-standing cultural conflicts, dynamic facilitation is an excellent methodology to help the sides come to a shared understanding of what steps can be taken to advance both parties’ goals. The facilitator walks each side through describing why they believe what they do about the issue. From that place of deeply listening to each other, it is often more possible to find common ground and shared values. Dynamic Facilitators are trained in everything from transpersonal psychology to intergenerational trauma, to mediator techniques.</p><p><strong>Resources and Practicioners</strong></p><ul><li><a href="https://www.amazon.com/Conflict-Creative-Collaboration-Dynamic-Facilitation/dp/1626526117/ref=sr_1_1?s=books&amp;ie=UTF8&amp;qid=1394491921&amp;sr=1-1&amp;keywords=from+conflict+to+creative+collaboration">From Conflict to Creative Collaboration: A User’s Guide to Dynamic Facilitation: Rosa Zubizarreta: 9781626526112: Amazon.com: Books</a></li><li>Rosa Zubizarreta: <a href="https://www.linkedin.com/in/rosazubizarreta/">https://www.linkedin.com/in/rosazubizarreta/</a></li><li>Sofia Bustamante: <a href="https://www.linkedin.com/in/olasofia/">https://www.linkedin.com/in/olasofia/</a></li><li>Simone Torrey: <a href="https://www.linkedin.com/in/simonetorrey/">https://www.linkedin.com/in/simonetorrey/</a> — Simone is not specifically a dynamic facilitation practitioner, but she has worked with psychedelic communities and specializes in gender-related conflicts in corporations and communities. She is also experienced with anti-racism work.</li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c60531e3b342" width="1" height="1" alt=""><hr><p><a href="https://medium.com/psychedstudio/psychedelic-startups-investors-regenerative-business-models-for-every-organization-c60531e3b342">Psychedelic Startups &amp; Investors: Regenerative Business Models for Every Organization</a> was originally published in <a href="https://medium.com/psychedstudio">PSYCHEDSTUDIO</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Tabula Rasa Ventures— Our Core Beliefs]]></title>
            <link>https://medium.com/psychedstudio/tabula-rasa-ventures-our-core-beliefs-170cde73e1f8?source=rss----64102bad6192---4</link>
            <guid isPermaLink="false">https://medium.com/p/170cde73e1f8</guid>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[psychedelics]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[impact-investing]]></category>
            <dc:creator><![CDATA[Marik Hazan]]></dc:creator>
            <pubDate>Thu, 14 Nov 2019 16:40:18 GMT</pubDate>
            <atom:updated>2019-11-14T16:40:18.662Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*guVXD59eToSRjBRSqdvCiw.jpeg" /></figure><p>I had never heard of a VC firm that had a mission. Values were replaced by a compelling thesis and strategy to maximize returns.</p><p>As we interacted with more nonprofit founders, researchers, and folks from the psychedelics community we realized that there was no greater priority than examining ourselves. What were our goals? What did we hope to contribute? What question were we trying to answer?</p><p><em>This</em> is where our searching brought us.</p><h3>Our Question</h3><p>What does it mean to be a VC with a conscience?</p><h3>Mission</h3><p>To build the bridge between a values neutral world of capital and the values driven world of psychedelics. To provide researchers, activists, and community members with the power to democratically steer capital towards solutions that benefit our world.</p><h3>Vision</h3><p>To build a replicable economic infrastructure that prioritizes our Earth, humanity, and all living beings.</p><h3>Values</h3><p><strong>Holistic, Ecosystem Focused </strong>— Developing an ecosystem, not a single entity or a “portfolio”. Understanding that the best possible future is one where entities work together and support one another collaboratively. A rising tide lifts all ships.</p><p><strong>Humbleness and Reverence</strong> — Recognizing that psychedelics have spiritual roots. Understanding that we are always learning and growing. Staying humble, aware, and in deep respect of everyone we come into contact with.</p><p><strong>Scientific Rigor </strong>— Rigorous research over decades of time brought psychedelics and their associated therapies to where they are today. We support companies that develop products which are rigorously tested to bring benefit for their consumers. We recognize and integrate the high bar of academia into our investment decisions.</p><p><strong>Legality</strong> — We recognize the role law has played in shaping psychedelic culture, its history, and its present. We put a premium on legal compliance and we don’t support companies that compromise legality.</p><p><strong>Equity</strong> — We are a VC with a conscience. Our “conscience” consists of members from academia, nonprofits, and the broader psychedelics community. We incorporate the judgement of the psychedelics ecosystem into every decision we make, empowering the entire community to steer capital in the direction that is most beneficial for everyone involved.</p><p><strong>Patiently Revolutionary</strong> — Working towards creating long lasting, meaningful change that is powerful enough to combat inequality on all fronts. Doing so methodically, strategically, with deep thoughtfulness and patience.</p><p><strong>Tikkun Olam</strong> — We recognize the role psychedelics play in repairing the world, prioritizing community, quality of life for all species, and the Earth. Being the resolution or solution and filling the role that is needed.</p><p><strong>Informing Awareness not Consumerism</strong> — Supporting companies that are built around brands which provide helpful information instead of pressure to make a purchase.</p><p><strong>Joy</strong> — We support teams composed of people that bring joy to everyone around them. Our team seeks to do the same. Through play, improvisation, rest, laughter, and renewal we will bring positive energy to every interaction.</p><p><strong>Win-Win</strong> — This is not a zero-sum game. We will always seek out the solution that results in the greatest possible benefit for everyone involved.</p><p>We hope that these words resonate and create even more space for conversation. If you want to contribute to what we’re building please get in touch: team@tabularasa.ventures.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=170cde73e1f8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/psychedstudio/tabula-rasa-ventures-our-core-beliefs-170cde73e1f8">Tabula Rasa Ventures— Our Core Beliefs</a> was originally published in <a href="https://medium.com/psychedstudio">PSYCHEDSTUDIO</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Venture Capital in Psychedelics]]></title>
            <link>https://medium.com/psychedstudio/venture-capital-in-psychedelics-1270e6ec4af8?source=rss----64102bad6192---4</link>
            <guid isPermaLink="false">https://medium.com/p/1270e6ec4af8</guid>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[investment]]></category>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[psychedelics]]></category>
            <dc:creator><![CDATA[Marik Hazan]]></dc:creator>
            <pubDate>Thu, 14 Nov 2019 15:13:14 GMT</pubDate>
            <atom:updated>2022-12-03T01:04:08.328Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*9PDTemUHATnIH3Vpz3ffuQ.png" /></figure><p>The majority of the psychedelics community has rarely made contact with the world of venture capital and high-growth startups.</p><p>This is dangerous because it doesn’t allow for those that work with psychedelic substances to understand what the next 10 years will bring their way… and as of right now the future <a href="https://hereandnowstudios.com/we-will-call-it-pala">doesn’t look too bright</a>.</p><p>A Venture Capital (VC) firm, is in its simplest form just an entity that invests the money of rich folks into the companies that it believes will become the most financially valuable. There are of course other considerations for some investing groups such as: patient outcomes, environmental impact and sustainability, and general <a href="https://en.wikipedia.org/wiki/Environmental,_social_and_corporate_governance">ESG methodologies</a>. But for the most part VC firms work to provide a <em>return</em>, financial gain,<em> </em>to their investors by providing cash to startups that want to grow their business fast.</p><p>Let’s say that you are a psychotherapist who’s been running their own clinic for a few years. You were trained by <a href="https://maps.org/">MAPS</a> to do psychedelic assisted therapy and have incorporated the service into your practice. Business is booming. Everyone wants access to your transformative care.</p><p>Perhaps you want to open up a second clinic where you can hire on some more therapists with the proper training, but you don’t have the money saved up yet to open up another location.</p><p>You could wait a few years, go to a bank to get a loan, or you could seek out an investment.</p><iframe src="https://cdn.embedly.com/widgets/media.html?src=https%3A%2F%2Fgiphy.com%2Fembed%2F7HPgM7IltO4QU%2Ftwitter%2Fiframe&amp;url=https%3A%2F%2Fgiphy.com%2Fgifs%2Fmoney-7HPgM7IltO4QU&amp;image=https%3A%2F%2Fmedia.giphy.com%2Fmedia%2F7HPgM7IltO4QU%2Fgiphy.gif&amp;key=a19fcc184b9711e1b4764040d3dc5c07&amp;type=text%2Fhtml&amp;schema=giphy" width="435" height="244" frameborder="0" scrolling="no"><a href="https://medium.com/media/03ad6b60d6b9ab04a0badf0edf2dbfb3/href">https://medium.com/media/03ad6b60d6b9ab04a0badf0edf2dbfb3/href</a></iframe><p>If you choose to go raise money for your venture you’ll be met with a lot of questions most of which will be pointed at one thing: scale. Most investors won’t put down capital for you to just open up one additional clinic. You’ll need to describe a vision of growing fast and scaling your brand to be the most impactful, widely distributed clinic on the planet.</p><p>Why? Because investors lose money on most investments that they make. Almost all of their returns are made from the few investments that knock it out of the park. The billion dollar unicorn that can grow their money more than 100x.</p><p>None of this is to say that good companies that can generate a high return don’t exist, but it’s very difficult to find that balance. Within our current system, companies need to compete with one another. That competition plays out through cutting costs, moving quickly, and oftentimes deprioritizing people, the environment, and quality.</p><p>It’s also very difficult to prioritize long term results. Every VC firm collects a new pool of money every few years called a <em>fund</em>. Most funds only run for 7 years, 10 years on the long end. Within 10 years you need to see a company sold off or going public for you to cash out and see the fruits of your investment. A company that has a 25 year mission to revolutionize patient care, but has to suffer losses for the first 10? Not going to happen.</p><p>As I mentioned earlier, there are strategies for forming firms around values, impact, and longer term results. But it’s extremely difficult. A firm can focus on investing in B Corps, but B Corp status is very time and resource intensive to pursue. There are a few companies in the space that have done it including MAPS and <a href="https://thethirdwave.co/">The Third Wave</a>, but it’ll be a long road before we see a meaningful percentage of psychedelics companies adopt this style of doing business.</p><p>All of us from <a href="http://aurynfund.org/">Auryn Fund</a>, to <a href="https://fieldtriphealth.com/">Field Trip</a>, to our own <a href="https://tabularasaventures.webflow.io/">Tabula Rasa Ventures</a> are trying hard to make sure that the future of this industry reflects the incredible community that’s built it. But we need to be having more open conversations along with detailed strategies for how to do investment right.</p><p>If you read the <a href="https://hereandnowstudios.com/we-will-call-it-pala">PALA story</a>, it resonated strongly because it’s the future that many of us currently see approaching. But now that we’re aware of what the coming years will bring, what are the tangible steps for us to change it?</p><p>Over the coming months we’ll be releasing podcasts, articles, and stories that cover this specific topic. Leave us a comment with your thoughts and who you’d like to hear from. We’ll make sure to reach out.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1270e6ec4af8" width="1" height="1" alt=""><hr><p><a href="https://medium.com/psychedstudio/venture-capital-in-psychedelics-1270e6ec4af8">Venture Capital in Psychedelics</a> was originally published in <a href="https://medium.com/psychedstudio">PSYCHEDSTUDIO</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>